Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001553878-14-000017
Filing Date
2014-10-30
Accepted
2014-10-30 17:03:47
Documents
1
Period of Report
2014-10-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 7606
  Complete submission text file 0001553878-14-000017.txt   9111
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 88 SIDNEY ST CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-494-0171
SCHIMMEL PAUL (Reporting) CIK: 0001236447 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 141183923